What obligations does the authorised representative, the provider of an AI system and the body governed by public law have under Article 71 of the AI Act?

You determine this yourself

• Applies where a provider or authorised representative places an Annex III high-risk AI system on the market or puts it into service and registers itself and that system in accordance with Article 49, where that same party registers a system considered not to be high-risk pursuant to Article 6(3), or where a deployer that is, or that acts on behalf of, a public authority, agency or body registers itself, selects the system and registers its use.
• Article 49(5) provides that high-risk AI systems referred to in point 2 of Annex III are registered at national level. For those systems the registration therefore does not run through the Article 71 EU database.
• Paragraph 4 excludes the section referred to in Article 49(4) from public availability. For the systems referred to in points 1, 6 and 7 of Annex III in the areas of law enforcement, migration, asylum and border control management, registration takes place in a secure non-public section of the database, with fewer fields than the full Sections: Section A, points 1 to 10 with the exception of points 6, 8 and 9; Section B, points 1 to 5 and points 8 and 9; Section C, points 1, 2 and 3; and points 1, 2, 3 and 5 of Annex IX. Only the Commission and the national authorities referred to in Article 74(8) have access to those sections. Mind the cross-reference: Article 49(4) was not amended by Regulation (EU) 2026/1744 and therefore still names point 9 of Section B, while Article 1, point (42), of that same Regulation deleted that point. There is nothing left to fill in there.
• Paragraph 4 additionally excludes the section referred to in Article 60(4), point (c). The main rule there is not a secure section: the provider or prospective provider registers the testing in real world conditions in accordance with Article 71(4), with a Union wide unique single identification number and the information specified in Annex IX. Under the third sentence of paragraph 4 that information is accessible only to market surveillance authorities and the Commission, unless the provider or prospective provider has given consent for also making it accessible to the public. Only for points 1, 6 and 7 of Annex III does the testing registration go into the secure non-public section under Article 49(4), point (d), and for point 2 of Annex III to national level under Article 49(5).